Aro Biotherapeutics
Aro Biotherapeutics develops tissue-targeted genetic medicines using its Centyrin platform to deliver RNA therapeutics for serious diseases.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $41.5M
About
Aro Biotherapeutics develops tissue-targeted genetic medicines using its Centyrin platform to deliver RNA therapeutics for serious diseases.
RNA TherapeuticsGenetics & GenomicsBiologics
Funding History
1Total raised:$41.5M
Venture$41.5M